NIH-funded research NIH-funded research

AI-guided IV nutrition for premature newborns

Official title: An AI-driven total parenteral nutrition platform for cost-effective and scientifically personalized nutrition for premature newborns

Funded at Takeoff41, INC. · NIH-11335827 · Data updated 2026-11-12

This project will use artificial intelligence to create standardized yet personalized IV nutrition (TPN) for premature babies in neonatal intensive care units.

More Premature research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionTakeoff41, INC.
NIH-funded
Lab location1 site (Portola Valley, United States)
Project startSeptember 13, 2024
Project endAugust 31, 2027
Funding year2025
Award (this year)$1,061,217
NIH project number4R42HD115517-02
Project IDNIH-11335827 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are premature newborns in the NICU who require total parenteral nutrition (typically very-low-birthweight or medically unable to feed by mouth).

Less likely to help

Full-term babies or infants who do not need intravenous nutrition, and babies whose care requires highly unusual or bespoke formulas, are unlikely to benefit directly.

What this research studies

As a parent, you should know this project builds an AI platform from ten years of clinical data linking TPN formulas to infant outcomes so nutrition can be tailored safely. The team plans to group similar TPN compositions into a manageable set of standardized units that can be centrally manufactured while keeping personalization for each baby. The AI model also uses mother and baby electronic health records to predict risks and suggest appropriate TPN choices. Finally, the platform will be tested in real NICU settings to show it works at least as well as current care.

Why it matters

Potential benefit: If successful, this could lower medication errors, reduce costs, and provide better-tailored nutrition that may improve growth and health outcomes for premature infants.

How similar studies have gone: Prior work exists using EHR-based AI to predict newborn risks, but using AI to create standardized, centrally manufactured TPN units is a novel approach with limited prior clinical testing.

Where this research is happening

  • Takeoff41, INC.
    Portola Valley, United States
    Active

Researchers

  • Principal investigator: Phongpreecha, Thanaphong — Takeoff41, INC.
  • Study coordinator: Phongpreecha, Thanaphong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.